DOI:

Taking the "measure" of a profession

Patrick W. Serruys, Editor-in-Chief

Dear Colleagues,

There are many ways to gauge the maturity of a speciality and one of them – perhaps not the most reliable – is the amount of publications that exist in that field. If this is the case, then we certainly have come of age, if only you were to look at the current expansion of EuroIntervention, and the recent creation in the United States of two journals, JACC Intervention and Circulation Intervention.

But in this modern world it is not just through our loyal competition that we, or our profession are judged, nor is this measuring of our value strictly left to our peers, but by our ability to be referenced on PubMed...and for the moment we are not. However, we have again proffered our candidacy, and asked them to re-consider a decision that was, if nothing else, very close the first time we were considered, just short of what was necessary to be accepted, with a score of 2.5 out of 5.

This time we are deeply honoured by our colleagues throughout the speciality who have written in support of our candidature, freely joining their names to our request: Frans van der Werf, Editor-in-Chief of the European Heart Journal and Chairman of the Publications committee of the European Society of Cardiology; Kim Fox, President of the European Society of Cardiology (ESC) and former Associate Editor for Heart; William Wijns, President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Chairman of the ESC Committee for European Relations and Board Member of the World Heart Foundation; Spencer B. King III, Editor himself of our distinguished competition, JACC Cardiovascular Medicine, and Professor emeritus at Emory University and Valentin Fuster, Editor-in-Chief, Nature Clinical Practice Cardiovascular Medicine. With friends like these, and your own continued support, I can only say that I am confident for the future – and not just concerning our ability to be listed on PubMed.

Invitation for the Special Session

And it is a future that is truly growing in the best possible sense, rich in opportunities for you and ourselves to present new and challenging work. EuroIntervention will participate in the next EuroPCR for the first time with our own dedicated session, and one of the highlights of this session will be you: from those articles accepted up until the 25th of February for publication in the journal, six will be chosen for oral presentation, publicly by their authors during this session before a distinguished panel of experts.

How should I treat it?

At the same time, the journal, and our complementary website, will be evolving with a new feature, another way of working with, and learning from, case reports. Dubbed “How should I treat it?”, an accepted case report will be presented without its conclusion. The description and diagnostic components will be provided, and then an external expert will be invited to comment on how he or she would manage the particular case. You will be invited to respond as well. We will then, of course, publish the actual outcome of the particular case.

We hope that by doing this we can further encourage an interactivity and an ongoing dialogue between ourselves and our readers. Join us then as we examine the different ways of approaching specific cases, and join us as well, submitting your papers, participating as readers, and being with us, in May, at our new dedicated session.

Thank you.

Volume 3 Number 4
Jan 20, 2008
Volume 3 Number 4
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00061 Mar 3, 2025
CIED and tricuspid regurgitation – a LEADing problem?
Andreas M et al
free

Editorial

10.4244/EIJ-E-25-00006 Mar 3, 2025
Tricuspid annuloplasty: a piece of the puzzle or the whole picture?
Nickenig G and Vogelhuber J
free

Editorial

10.4244/EIJ-E-24-00074 Mar 3, 2025
Access site closure after TAVI: invincible sutures
Abdel-Wahab M and Dumpies O
free

Flashlight

10.4244/EIJ-D-24-00816 Mar 3, 2025
Double mitral and tricuspid transcatheter valve replacement
Leurent G et al

Original Research

10.4244/EIJ-D-23-01033 Mar 3, 2025
Outcomes of tricuspid transcatheter edge-to-edge repair in subjects with endocardial leads
Goebel B et al

Original Research

10.4244/EIJ-D-24-00120 Mar 3, 2025
A propensity-matched comparison of plug- versus suture-based vascular closure after TAVI
Grundmann D et al

Research Correspondence

10.4244/EIJ-D-24-00741 Mar 3, 2025
Balloon-expandable SAPIEN 3 Ultra valve in intermediate sizing zones: insights from the OPERA-TAVI registry
Costa G et al
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
54

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
33.8

Translational research

10.4244/EIJ-D-23-00308 Nov 17, 2023
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 – impact of pre- and post-dilatation on final THV expansion
Meier D et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
22.55

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00774 Oct 19, 2018
Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease
Azzalini L et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved